It’s not possible to say, at this point, for what percentage of people Banjo ‘works’.
Pain, fatigue and other signs and symptoms of inflammation are present in a large number of conditions, some of which are quite severe and difficult to treat, others of which have generally milder symptoms.
‘Common sense’ suggests that a greater percent of those with mild symptoms, or with conditions characterized by mild symptoms, would respond favorably to Banjo. However, since the mechanism of action of Banjo remains unknown, Banjo may ultimately prove to be more effective against certain severe symptoms and in conditions generally considered more difficult to treat. Nonetheless, the data that we do have may provide some general sense of the overall frequency with which Banjo provides symptomatic relief to users.
To date, we have the greatest amount of data on three conditions: fibromyalgia, osteoarthritis, migraine, and Ehlers-Danlos syndrome.
It should be emphasized that the data presented here is not derived from controlled clinical studies, but instead represents a combination of ‘survey data’ and other consumer feedback.
We do plan to conduct controlled clinical trials in the near future, most likely beginning with one or more trials on the use of Banjo in the treatment of fibromyalgia, followed next by trials investigating the use of Banjo as a treatment for osteoarthritis.
We believe that many researchers, apart from and outside of the company’s control or influence, will eventually investigate Banjo, just as there are many publications on products like glucosamine, very few of which are sponsored by manufacturers of those products.
We have more data on fibromyalgia than on any other single condition.
Based on our data, it appears that approximately 80% of those with fibromyalgia will experience a significant degree of symptomatic relief within 30 days after beginning use of Banjo.
Nearly all of those with osteoarthritis who have used Banjo have reported a significant reduction in joint pain. Many of those with osteoarthritis who have successfully used Banjo have reported that, once pain is relieved, they need only use Banjo intermittently, and rather infrequently, to maintain freedom from joint pain.
Approximately 60-70% of those with migraine who use Banjo on a daily basis obtain complete cessation of migraine within 30 days. A significant percent of the remainder see a reduction in the severity and/or frequency of attacks within that same time frame.
Nearly all those with Ehlers-Danlos syndrome (EDS) have reported a significant reduction in pain and fatigue as a result of having used Banjo.
EDS results from an inborn (genetic) defect in connective tissue. As a result, a majority of those with EDS experience chronic pain and fatigue, both of which are often severe.
Since Banjo cannot, of course, repair the defect in connective tissue, the symptomatic relief of pain resulting from use of Banjo is generally only partial. Those with EDS have, on average, reported pain reduction in the 30% to 50% range within one to two months after having first started using Banjo.
Somewhat remarkably, relief of fatigue in those with EDS appears both more rapid and more substantial. A number of users with EDS have particularly remarked on the benefit of relief from fatigue.